UMB Bank n.a. Trims Stake in Mettler-Toledo International, Inc. $MTD

UMB Bank n.a. cut its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 20.8% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 114 shares of the medical instruments supplier’s stock after selling 30 shares during the period. UMB Bank n.a.’s holdings in Mettler-Toledo International were worth $134,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in Mettler-Toledo International by 1.2% in the first quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier’s stock worth $3,003,485,000 after buying an additional 30,535 shares in the last quarter. Alliancebernstein L.P. boosted its position in Mettler-Toledo International by 21.6% during the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after purchasing an additional 126,147 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in Mettler-Toledo International by 5.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock valued at $568,032,000 after purchasing an additional 25,272 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its stake in Mettler-Toledo International by 11.9% in the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier’s stock valued at $479,673,000 after purchasing an additional 43,082 shares during the last quarter. Finally, GAMMA Investing LLC raised its holdings in Mettler-Toledo International by 131,246.3% in the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier’s stock worth $456,018,000 after purchasing an additional 385,864 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Trading Down 1.2%

Shares of NYSE:MTD opened at $1,241.91 on Thursday. The business has a 50-day moving average price of $1,269.03 and a 200 day moving average price of $1,185.85. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,521.01. The company has a market capitalization of $25.58 billion, a price-to-earnings ratio of 31.45, a PEG ratio of 3.77 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same quarter in the prior year, the company earned $9.65 EPS. Mettler-Toledo International’s revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, equities research analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the stock. Evercore ISI cut their price objective on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating on the stock in a research report on Monday, August 4th. Bank of America lifted their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a report on Monday. Citigroup upped their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research report on Thursday, August 21st. Barclays started coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an “overweight” rating and a $1,325.00 target price for the company. Finally, Robert W. Baird increased their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Five investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Mettler-Toledo International presently has an average rating of “Moderate Buy” and a consensus target price of $1,325.56.

Insider Buying and Selling

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of the business’s stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the sale, the insider owned 94 shares in the company, valued at approximately $123,012.16. The trade was a 63.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the transaction, the chief financial officer owned 5,095 shares in the company, valued at approximately $6,389,588.55. This trade represents a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,827 shares of company stock worth $2,371,208 in the last quarter. 1.94% of the stock is owned by insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.